Harnessing Evolution to Cure Prion Diseases

We take a science-first approach to engineering one-time, curative therapies. We are leveraging our deep expertise in prion biology to create designer molecules that directly address the root cause of prion diseases.

No Approved Treatments

Prion diseases are class of rapidly progressing and universally fatal neurodegenerative diseases. They affect approximately 1 in 5,000 humans.

The prognosis for patients is extremely poor, with survival measured in months following diagnosis. Despite their severity, there are no clinically approved treatments for prion diseases.

This stark reality underscores the urgent need for effective therapies.

Innovative Strategy

Therapeutic Research and Discovery

We specialize in advancing treatments for neurodegenerative diseases, focusing on prion disease research and development.

Cutting-Edge Research

Our team conducts pioneering research to understand prion biology, enabling us to design molecules that can combat prion diseases effectively.

Collaborative Partnerships

We collaborate with leading institutions and thought leaders with access to relevant human infectious prion pathogens to conduct efficacy studies.

Interventions in the central nervous system require state-of-the-art delivery solutions. Our in-house expertise in viral technology enables our therapeutic pipeline.

Engineering therapeutic delivery